Nektar Therapeutics (NKTR)

04:03 AM

Nektar presents preclinical data on NKTR-422 at ACR conference - TipRanks

04:03 AM

03:30 AM

Nektar Therapeutics Presents First Preclinical Data from Novel CSF-1 Program, NKTR-422, at 2024 American College of Rheumatology (ACR) Convergence - Longview News-Journal

03:30 AM

Nov 14, 2024

Eventide Asset Management's Strategic Acquisition of Nektar Ther - GuruFocus.com

Nov 14, 2024

Nov 14, 2024

Deep Track Capital, LP Reduces Stake in Nektar Therapeutics - GuruFocus.com

Nov 14, 2024

Nov 14, 2024

Multiple Catalysts Ahead For Nektar Therapeutics (NASDAQ:NKTR) - Seeking Alpha

Nov 14, 2024

Nov 11, 2024

NK Cell Therapy Clinical Trial Pipeline Appears Robust With 140+ Key Pharma Companies Actively Working in the Therapeutics Segment | DelveInsight - Yahoo Finance

Nov 11, 2024

Nov 10, 2024

Nektar Therapeutics to sell Alabama facility to Ampersand - MSN

Nov 10, 2024

Nov 10, 2024

NKTR-255 Shows Promise for Reversing Radiation-Induced Lymphopenia in NSCLC - Targeted Oncology

Nov 10, 2024

Nov 10, 2024

Nektar Therapeutics (NASDAQ:NKTR) Just Reported And Analysts Have Been Lifting Their Price Targets - Yahoo Canada Finance

Nov 10, 2024

Nov 09, 2024

Nektar Therapeutics (NASDAQ:NKTR) Q3 2024 Earnings Call Transcript - Insider Monkey

Nov 09, 2024

Nov 09, 2024

Nektar Therapeutics Third Quarter 2024 Earnings: Beats Expectations - Yahoo Finance

Nov 09, 2024

Nov 08, 2024

Earnings call: Nektar Therapeutics progresses with key clinical studies By Investing.com - Investing.com UK

Nov 08, 2024

Nov 08, 2024

Nektar Therapeutics (NKTR) Quarterly 10-Q Report - Quartz

Nov 08, 2024

Nov 08, 2024

Nektar Q3 Loss Narrower Than Expected, Pipeline Development in Focus - Yahoo Finance

Nov 08, 2024

Nov 08, 2024

Nektar reports NKTR-255 boosts lymphocyte recovery By Investing.com - Investing.com Australia

Nov 08, 2024

Nov 08, 2024

Nektar Therapeutics (NKTR) Q3 2024 Earnings Call Highlights: Str - GuruFocus.com

Nov 08, 2024

Nov 08, 2024

Nektar Therapeutics (NKTR) Q3 2024 Earnings Call Highlights: Strategic Moves and Financial Outlook - Yahoo Finance

Nov 08, 2024

Nov 08, 2024

Nektar: Q3 Earnings Snapshot - The Washington Post

Nov 08, 2024

Nov 08, 2024

Nektar Therapeutics Reports Stable Q3 Earnings for 2024 - TipRanks

Nov 08, 2024

Nov 07, 2024

Nektar Therapeutics Q3 2024 Earnings: Revenue Surpasses Estimate - GuruFocus.com

Nov 07, 2024

Nov 07, 2024

Nektar Therapeutics (NKTR) Reports Q3 Loss, Tops Revenue Estimates - Yahoo Finance

Nov 07, 2024

Nov 07, 2024

Nektar: Q3 Earnings Snapshot | National Business News | voiceofalexandria.com - Voice Of Alexandria

Nov 07, 2024

Nov 07, 2024

Nektar Therapeutics (NKTR) Tops Q3 EPS by 2c - StreetInsider.com

Nov 07, 2024

Nov 07, 2024

Nektar Therapeutics Narrows Losses, Sells Manufacturing Facility for $90M in Q3 | NKTR Stock News - StockTitan

Nov 07, 2024

Nov 07, 2024

Nektar Therapeutics Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com

Nov 07, 2024

Nov 07, 2024

Nektar releases promising phase 2 results for NKTR-255 in lymphopenia - MSN

Nov 07, 2024

Nov 07, 2024

Rx Rundown: Avid Biosciences, Novo Nordisk, Zealand Pharma and more - MM+M Online

Nov 07, 2024

Nov 07, 2024

Nektar reports NKTR-255 boosts lymphocyte recovery - Investing.com

Nov 07, 2024

Nov 07, 2024

Nektar Therapeutics (NKTR) and Collaborators Present Late-breaking Results from Phase 2 Study of NKTR-255 - StreetInsider.com

Nov 07, 2024

Nov 07, 2024

Nektar's NKTR-255 Shows Breakthrough Results in Cancer Treatment Study with MD Anderson | NKTR Stock News - StockTitan

Nov 07, 2024

Nov 07, 2024

Nektar Therapeutics (NKTR) Q3 2024 Earnings Call Highlights: Strategic Moves and Financial Outlook By GuruFocus - Investing.com Canada

Nov 07, 2024

Nov 06, 2024

Nektar Therapeutics to Participate in Upcoming Investor Conferences - Longview News-Journal

Nov 06, 2024

Nov 06, 2024

Moderna said to shuffle sales leadership; Vertex records first Casgevy sale - Yahoo Finance

Nov 06, 2024

Nov 05, 2024

Ampersand’s Acquisition of a Nektar’s Manufacturing Facility and Reagent Supply Business - Global Legal Chronicle

Nov 05, 2024

Nov 05, 2024

Nektar sells its PEGylation reagent manufacturing business - The Pharma Letter

Nov 05, 2024

Nov 05, 2024

Nektar divests manufacturing site and reagent arm for $90M - Endpoints News

Nov 05, 2024

Nov 05, 2024

Nektar announces agreement to sell Alabama manufacturing facility and reagent supply business - MSN

Nov 05, 2024

Nov 04, 2024

NKTRNektar Therapeutics Latest Stock News & Market Updates - StockTitan

Nov 04, 2024

Nov 04, 2024

Eczema Drug Developer Nektar Gains Analyst Confidence With 400% Upside Potential - Benzinga

Nov 04, 2024

Nov 04, 2024

Nektar pads wallet with $90M manufacturing plant sale to Ampersand - FiercePharma

Nov 04, 2024

Nov 04, 2024

Nektar divests Alabama facility to Ampersand for $90 million By Investing.com - Investing.com Canada

Nov 04, 2024

Nov 04, 2024

Nektar Therapeutics Sells Manufacturing Facility for $90M - TipRanks

Nov 04, 2024

Nov 04, 2024

Nektar divests Alabama facility to Ampersand for $90 million - Investing.com

Nov 04, 2024

Nov 04, 2024

Nektar Therapeutics (NASDAQ:NKTR) Now Covered by Piper Sandler - MarketBeat

Nov 04, 2024

Nov 04, 2024

Nektar Therapeutics (NKTR) to Sell Commercial PEGylation Reagent Manufacturing Business in Alabama - StreetInsider.com

Nov 04, 2024

Nov 04, 2024

Nektar Announces Definitive Agreement with Ampersand Capital Partners to Sell Its Commercial PEGylation Reagent Manufacturing Business in Alabama - StockTitan

Nov 04, 2024

Nov 04, 2024

Piper Sandler Starts Nektar Therapeutics (NKTR) at Overweight - StreetInsider.com

Nov 04, 2024

Nov 03, 2024

Ampersand Management LLC entered into an Asset Purchase Agreement to acquire Manufacturing Facility and Reagent Supply Business in Huntsville, Alabama of Nektar Therapeutics from Nektar Therapeutics for $90 million. - Marketscreener.com

Nov 03, 2024

Nov 01, 2024

Nektar Therapeutics (NKTR) Stock Surges Amidst Mixed Financials - GuruFocus.com

Nov 01, 2024

Nov 01, 2024

Nektar Therapeutics (NKTR) Scheduled to Post Earnings on Thursday - MarketBeat

Nov 01, 2024

Oct 31, 2024

Nektar to Announce Financial Results for the Third Quarter 2024 on Thursday, November 7, 2024, After Close of U.S.-Based Financial Markets - Longview News-Journal

Oct 31, 2024

Oct 31, 2024

Nektar Therapeutics (NASDAQ:NKTR) Receives Consensus Recommendation of "Hold" from Brokerages - MarketBeat

Oct 31, 2024

Oct 29, 2024

Nektar reports positive Phase 1b skin disease study results By Investing.com - Investing.com South Africa

Oct 29, 2024

Oct 29, 2024

Nektar reports positive Phase 1b skin disease study results - Investing.com India

Oct 29, 2024

Oct 29, 2024

Nektar Therapeutics (NKTR) Announces Publication of Results from Phase 1b Studies of Rezpegaldesleukin in Two Inflammatory Skin Diseases - StreetInsider.com

Oct 29, 2024

Oct 29, 2024

Nektar Announces Publication in Nature Communications of Results from Phase 1b Studies of Rezpegaldesleukin in Two Inflammatory Skin Diseases - StockTitan

Oct 29, 2024